BACE1 and Alzheimer disease: In the PC12 cellular AD model, miR-124 mimic or inhibitor could increase or decrease BACE1 expression, a key enzyme of APPβ generation, and a miR-124 inhibitor also increased the number of necrotic and apoptotic cells in vitro [35].